Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.

Retractable Technologies, Inc. (NYSA: RVP) recently made headlines by withdrawing its complaint in the United States Court of International Trade on January 8, 2025. The company issued a press release ...

Mayor Mike Johnston had only vetoed one bill during his time in office until Tuesday, when he said an ordinance removing certain restrictions for needle exchange sites was the "wrong solution." ...

BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

FlowBeams, creator of the BoldJet needle-free injection showcased itsbreakthrough medtech technology at CES 2025.The ...

Smart syringes redefine modern injection protocols through built-in safety features and automated monitoring. Heightened ...

Like something out of science fiction, the BoldJet can administer injections without even breaking the skin. No more fear of needles or infection risk.

The shock syringe is designed to deliver the medication rapidly. However, if a regular syringe is inserted too quickly or ...

Whether it be willful ignorance for the sake of scoring political points or a genuine misunderstanding of the broad range of strategies ...

Anticipated growth for ‘Saudi Arabia Human Insulin Market’ is significant from 2024 to 2032. The market showed steady growth in 2024 and is expected to continue rising due to strategies adopted by key ...

Retractable Technologies, Inc. (NYSE American: RVP) made an announcement through a press release regarding the declaration of ...